Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.
Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.
复制标题
DOI：
10.1016/j.puhe.2021.10.006
复制
发表时间：
2021-12
期刊：
影响因子：
5.2
通讯作者：
Vedhara K
中科院分区：
文献类型：
--
作者：
Knight H;Jia R;Ayling K;Bradbury K;Baker K;Chalder T;Morling JR;Durrant L;Avery T;Ball JK;Barker C;Bennett R;McKeever T;Vedhara K
严重急性呼吸道冠状病毒2型（SARS-CoV-2）于2019年底被发现，传播到200多个国家，导致全球近200万人死亡。安全有效疫苗的出现为摆脱大流行提供了一条途径，需要75-90%的疫苗接种率才能实现人口保护。疫苗犹豫是疫苗推广的问题;全球报告显示，只有73%的人口可能同意接种疫苗。因此，迫切需要制定公平和可获得的干预措施，以解决人口一级的疫苗犹豫问题。方法（& M）：我们报告了一项可扩展的数字干预措施的开发，旨在解决英国对COVID-19疫苗的犹豫并提高COVID-19疫苗的接种率。在动机访谈（MI）原则的指导下，干预措施包括一系列治疗对话，解决疫苗犹豫者的10个关键问题。干预措施的发展在四个阶段呈线性。在第一阶段，我们通过分析现有调查数据、快速系统的文献综述和公众参与研讨会，确定了COVID-19疫苗犹豫的常见原因。第二阶段包括与医学、免疫学和公共卫生专家的定性访谈。对数据的快速内容和专题分析提供了对常见疫苗问题的循证回应。第三阶段涉及通过与心理和数字行为改变专家的研讨会开展治疗对话。对话的发展，以解决问题，使用MI原则，包括拥抱阻力和支持自我效能。最后，第四阶段涉及对话的数字化和与公众的试点测试。数字干预提供了一种基于证据的方法，通过MI原则解决疫苗犹豫问题。对话是用户选择的，允许在非判断性的背景下探索与犹豫相关的问题。基于文本的内容和数字格式允许对不断变化的信息进行快速修改，并允许扩大传播范围。
Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.
登录
查看更多内容
影响因子：
7.8
作者：
Pogue K;Jensen JL;Stancil CK;Ferguson DG;Hughes SJ;Mello EJ;Burgess R;Berges BK;Quaye A;Poole BD
通讯作者：
Poole BD
影响因子：
39.2
作者：
Fisher, Kimberly A.;Bloomstone, Sarah J.;Mazor, Kathleen M.
通讯作者：
Mazor, Kathleen M.
影响因子：
2.9
作者：
Jia, Ru;Ayling, Kieran;Vedhara, Kavita
通讯作者：
Vedhara, Kavita
影响因子：
7.2
作者：
Gale, Randall C.;Wu, Justina;Midboe, Amanda M.
通讯作者：
Midboe, Amanda M.
影响因子：
7.8
作者：
Lin C;Tu P;Beitsch LM
通讯作者：
Beitsch LM